BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 17494792)

  • 1. Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany.
    Diel R; Nienhaus A; Loddenkemper R
    Chest; 2007 May; 131(5):1424-34. PubMed ID: 17494792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis.
    Diel R; Wrighton-Smith P; Zellweger JP
    Eur Respir J; 2007 Aug; 30(2):321-32. PubMed ID: 17504793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost effectiveness of interferon-gamma release assay for tuberculosis contact screening in Japan.
    Kowada A; Takahashi O; Shimbo T; Ohde S; Tokuda Y; Fukui T
    Mol Diagn Ther; 2008; 12(4):235-51. PubMed ID: 18652520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-optimisation of screening for latent tuberculosis in close contacts.
    Diel R; Nienhaus A; Lange C; Schaberg T
    Eur Respir J; 2006 Jul; 28(1):35-44. PubMed ID: 16571615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced cost-benefit analysis of strategies for LTBI screening and INH chemoprevention in Germany.
    Diel R; Schaberg T; Loddenkemper R; Welte T; Nienhaus A
    Respir Med; 2009 Dec; 103(12):1838-53. PubMed ID: 19682884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of a new interferon-based blood assay, QuantiFERON-TB Gold, in screening tuberculosis contacts.
    Marra F; Marra CA; Sadatsafavi M; Morán-Mendoza O; Cook V; Elwood RK; Morshed M; Brunham RC; Fitzgerald JM
    Int J Tuberc Lung Dis; 2008 Dec; 12(12):1414-24. PubMed ID: 19017451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of interferon-gamma release assay for systematic tuberculosis screening of healthcare workers in low-incidence countries.
    Kowada A; Takasaki J; Kobayashi N
    J Hosp Infect; 2015 Feb; 89(2):99-108. PubMed ID: 25559158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis.
    Diel R; Loddenkemper R; Meywald-Walter K; Niemann S; Nienhaus A
    Am J Respir Crit Care Med; 2008 May; 177(10):1164-70. PubMed ID: 18276940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis.
    Oxlade O; Schwartzman K; Menzies D
    Int J Tuberc Lung Dis; 2007 Jan; 11(1):16-26. PubMed ID: 17217125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of different screening strategies (single or dual) for the diagnosis of tuberculosis infection in healthcare workers.
    del Campo MT; Fouad H; Solís-Bravo MM; Sánchez-Uriz MA; Mahíllo-Fernández I; Esteban J
    Infect Control Hosp Epidemiol; 2012 Dec; 33(12):1226-34. PubMed ID: 23143360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Mycobacterium tuberculosis infection in United States Navy recruits using the tuberculin skin test or whole-blood interferon-gamma release assays.
    Mazurek GH; Zajdowicz MJ; Hankinson AL; Costigan DJ; Toney SR; Rothel JS; Daniels LJ; Pascual FB; Shang N; Keep LW; LoBue PA
    Clin Infect Dis; 2007 Oct; 45(7):826-36. PubMed ID: 17806046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers.
    de Perio MA; Tsevat J; Roselle GA; Kralovic SM; Eckman MH
    Arch Intern Med; 2009 Jan; 169(2):179-87. PubMed ID: 19171815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation.
    Auguste P; Tsertsvadze A; Pink J; Court R; Seedat F; Gurung T; Freeman K; Taylor-Phillips S; Walker C; Madan J; Kandala NB; Clarke A; Sutcliffe P
    Health Technol Assess; 2016 May; 20(38):1-678. PubMed ID: 27220068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of QuantiFERON-TB test vs. tuberculin skin test in the diagnosis of latent tuberculosis infection.
    Deuffic-Burban S; Atsou K; Viget N; Melliez H; Bouvet E; Yazdanpanah Y
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):471-81. PubMed ID: 20202306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis.
    Pooran A; Booth H; Miller RF; Scott G; Badri M; Huggett JF; Rook G; Zumla A; Dheda K
    BMC Pulm Med; 2010 Feb; 10():7. PubMed ID: 20170555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.
    Abubakar I; Lalvani A; Southern J; Sitch A; Jackson C; Onyimadu O; Lipman M; Deeks JJ; Griffiths C; Bothamley G; Kon OM; Hayward A; Lord J; Drobniewski F
    Health Technol Assess; 2018 Oct; 22(56):1-96. PubMed ID: 30334521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost effectiveness of the interferon-γ release assay for tuberculosis screening of hemodialysis patients.
    Kowada A
    Nephrol Dial Transplant; 2013 Mar; 28(3):682-8. PubMed ID: 23239835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of Quantiferon®-TB Gold-in-Tube versus tuberculin skin testing for contact screening and treatment of latent tuberculosis infection in Brazil.
    Steffen RE; Caetano R; Pinto M; Chaves D; Ferrari R; Bastos M; de Abreu ST; Menzies D; Trajman A
    PLoS One; 2013; 8(4):e59546. PubMed ID: 23593145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for tuberculosis infection in spanish healthcare workers: Comparison of the QuantiFERON-TB gold in-tube test with the tuberculin skin test.
    Alvarez-León EE; Espinosa-Vega E; Santana-Rodríguez E; Molina-Cabrillana JM; Pérez-Arellano JL; Caminero JA; Serrano-Aguilar P
    Infect Control Hosp Epidemiol; 2009 Sep; 30(9):876-83. PubMed ID: 19614541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. School based screening for tuberculosis infection in Norway: comparison of positive tuberculin skin test with interferon-gamma release assay.
    Winje BA; Oftung F; Korsvold GE; Mannsåker T; Ly IN; Harstad I; Dyrhol-Riise AM; Heldal E
    BMC Infect Dis; 2008 Oct; 8():140. PubMed ID: 18928541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.